Kourtney Kardashian Barker’s supplement brand, Lemme, has faced significant backlash and criticism over several of its products, most notably an “Ozempic-style” weight-loss supplement, as well as controversial offerings for cellulite reduction and vaginal health. The brand, launched in September 2022 by the reality star known for her health-conscious lifestyle, has been accused by fans and medical experts alike of exploiting insecurities, making misleading claims, and engaging in a “cash grab.”

The latest product to draw ire is Lemme GLP-1 Daily, unveiled last week as an “Ozempic-style” weight-loss supplement. Ozempic, originally a diabetes medication, gained popularity as a weight-loss aid in 2022 due to its active ingredient, a synthetic GLP-1 hormone that slows digestion, reduces hunger, and aids in shedding body weight. Kourtney Kardashian’s sisters, Khloe and Kylie, have also faced speculation regarding Ozempic use. While Lemme’s new pill does not contain the key synthetic GLP-1 ingredients found in Ozempic, it is marketed as a natural alternative designed to “reduce body weight, visceral fat, and hip and waist circumference” by naturally increasing GLP-1 levels using lemon and saffron extracts. The brand promoted a WWD article where Kourtney expressed her desire to be “in on the Ozempic boom,” and an email described the product as “a GLP-1 solution without the side effects” of Ozempic. A one-time purchase of the 30-serving pills costs £69.

However, medical professionals and consumers have strongly criticized Lemme GLP-1 Daily. Plastic surgeon Naveen Cavale emphasized that Ozempic contains semaglutide, a rigorously tested GLP-1 receptor proven to promote significant weight loss by mimicking the body’s natural GLP-1 hormone. He stated that Lemme’s supplement lacks this key ingredient and that if it did contain GLP-1, it would be classified as a drug, not a supplement. Cavale added, “While it claims to boost GLP-1 levels using plant-based extracts, there is little to no clinical evidence to support significant weight loss from these ingredients.” Fans have labeled the marketing as a “facade” and “false marketing,” with one commenter stating, “These do not mimic GLP-1 medications as nothing oral can mimic it for weight loss. It will systemically be engulfed by enzymes in a few minutes.”

Another controversial product, Lemme Smooth, launched in June, is a daily tablet claimed to “combat cellulite from the inside out” and reduce it in just 28 days. Containing French Cantaloupe Melon (SOD B Dimpless), an antioxidant, the product has been marketed with